The Food and Drug Administration (FDA) on Thursday approved the anti-wrinkle injection Daxxify, setting up competition for Botox, which has dominated the market for two decades. Manufacturer Reva… ...

Four cosmetic dermatologists weigh in on the pros and cons of each neurotoxin—including Botox, Xeomin, Dysport, Jeuveau, and Daxxify—and explain how they work.

The U.S. Food and Drug Administration on Thursday approved Revance Therapeutics' anti-wrinkle injection, setting up a challenger for market leader AbbVie's Botox that has long dominated the ...

F.D.A. OKs Daxxify, an Anti-Wrinkle Drug and Botox Competitor The treatment lasts for six months in half of its users, company studies showed, representing the first major advance in facial ...